AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 290: H1862-H1870, 2006. First published December 9, 2005; doi:10.1152/ajpheart.00651.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/H1862    most recent
00651.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, X.-L.
Right arrow Articles by Kunsch, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, X.-L.
Right arrow Articles by Kunsch, C.

Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression

Xi-Lin Chen,1 Geraldine Dodd,1 Suzanne Thomas,1 Xiaolan Zhang,2 Martin A. Wasserman,1 Brad H. Rovin,2 and Charles Kunsch1

1Discovery Research, AtheroGenics, Incorporated, Alpharetta, Georgia; and 2Department of Internal Medicine and Dorothy M. Davis Heart and Lung Research Institute, Ohio State University College of Medicine and Public Health, Columbus, Ohio

Submitted 16 June 2005 ; accepted in final form 30 November 2005

The antioxidant response element (ARE) is a transcriptional control element that mediates expression of a set of antioxidant proteins. NF-E2-related factor 2 (Nrf2) is a transcription factor that activates ARE-containing genes. In endothelial cells, the ARE-mediated genes are upregulated by atheroprotective laminar flow through a Nrf2-dependent mechanism. We tested the hypothesis that activation of ARE-regulated genes via adenovirus-mediated expression of Nrf2 may suppress redox-sensitive inflammatory gene expression. Expression of Nrf2 in human aortic endothelial cells (HAECs) resulted in a marked increase in ARE-driven transcriptional activity and protected HAECs from H2O2-mediated cytotoxicity. Nrf2 suppressed TNF-{alpha}-induced monocyte chemoattractant protein (MCP)-1 and VCAM-1 mRNA and protein expression in a dose-dependent manner and inhibited TNF-{alpha}-induced monocytic U937 cell adhesion to HAECs. Nrf2 also inhibited IL-1beta-induced MCP-1 gene expression in human mesangial cells. Expression of Nrf2 inhibited TNF-{alpha}-induced activation of p38 MAP kinase. Furthermore, expression of a constitutively active form of MKK6 (an upstream kinase for p38 MAP kinase) partially reversed Nrf2-mediated inhibition of VCAM-1 expression, suggesting that p38 MAP kinase, at least in part, mediates Nrf2's anti-inflammatory action. In contrast, Nrf2 did not inhibit TNF-{alpha}-induced NF-{kappa}B activation. These data identify the Nrf2/ARE pathway as an endogenous atheroprotective system for antioxidant protection and suppression of redox-sensitive inflammatory genes, suggesting that targeting the Nrf2/ARE pathway may represent a novel therapeutic approach for the treatment of inflammatory diseases such as atherosclerosis.

antioxidant response element; monocyte chemoattractant protein-1; vascular cell adhesion molecule-1; tumor necrosis factor-{alpha}



Address for reprint requests and other correspondence: X. Chen, Discovery Research, AtheroGenics, Inc., 8995 Westside Parkway, Alpharetta, GA 30004 (e-mail: xchen{at}atherogenics.com)




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. H. Heiss, D. Schachner, E. R. Werner, and V. M. Dirsch
Active NF-E2-related Factor (Nrf2) Contributes to Keep Endothelial NO Synthase (eNOS) in the Coupled State: ROLE OF REACTIVE OXYGEN SPECIES (ROS), eNOS, AND HEME OXYGENASE (HO-1) LEVELS
J. Biol. Chem., November 13, 2009; 284(46): 31579 - 31586.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Zakkar, K. Van der Heiden, L. A. Luong, H. Chaudhury, S. Cuhlmann, S. S. Hamdulay, R. Krams, I. Edirisinghe, I. Rahman, H. Carlsen, et al.
Activation of Nrf2 in Endothelial Cells Protects Arteries From Exhibiting a Proinflammatory State
Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1851 - 1857.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Dreger, K. Westphal, N. Wilck, G. Baumann, V. Stangl, K. Stangl, and S. Meiners
Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2
Cardiovasc Res, September 4, 2009; (2009) cvp279v2.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. G. Morris, S. M. Waters, S. D. McCarthy, J. Patton, B. Earley, R. Fitzpatrick, J. J. Murphy, M. G. Diskin, D. A. Kenny, A. Brass, et al.
Pleiotropic effects of negative energy balance in the postpartum dairy cow on splenic gene expression: repercussions for innate and adaptive immunity
Physiol Genomics, September 1, 2009; 39(1): 28 - 37.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. M. Cortese-Krott, C. V. Suschek, W. Wetzel, K.-D. Kroncke, and V. Kolb-Bachofen
Nitric oxide-mediated protection of endothelial cells from hydrogen peroxide is mediated by intracellular zinc and glutathione
Am J Physiol Cell Physiol, April 1, 2009; 296(4): C811 - C820.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Liu, A. T. Dinkova-Kostova, and P. Talalay
Coordinate regulation of enzyme markers for inflammation and for protection against oxidants and electrophiles
PNAS, October 14, 2008; 105(41): 15926 - 15931.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Xue, Q. Qian, A. Adaikalakoteswari, N. Rabbani, R. Babaei-Jadidi, and P. J. Thornalley
Activation of NF-E2-Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease
Diabetes, October 1, 2008; 57(10): 2809 - 2817.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H.-K. Jyrkkanen, E. Kansanen, M. Inkala, A. M. Kivela, H. Hurttila, S. E. Heinonen, G. Goldsteins, S. Jauhiainen, S. Tiainen, H. Makkonen, et al.
Nrf2 Regulates Antioxidant Gene Expression Evoked by Oxidized Phospholipids in Endothelial Cells and Murine Arteries In Vivo
Circ. Res., July 3, 2008; 103(1): e1 - e9.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. O. Fledderus, R. A. Boon, O. L. Volger, H. Hurttila, S. Yla-Herttuala, H. Pannekoek, A.-L. Levonen, and A. J.G. Horrevoets
KLF2 Primes the Antioxidant Transcription Factor Nrf2 for Activation in Endothelial Cells
Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1339 - 1346.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
X. Zhao, G. Sun, J. Zhang, R. Strong, P. K. Dash, Y. W. Kan, J. C. Grotta, and J. Aronowski
Transcription Factor Nrf2 Protects the Brain From Damage Produced by Intracerebral Hemorrhage
Stroke, December 1, 2007; 38(12): 3280 - 3286.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Villacorta, J. Zhang, M. T. Garcia-Barrio, X.-l. Chen, B. A. Freeman, Y. E. Chen, and T. Cui
Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H770 - H776.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A.-L. Levonen, M. Inkala, T. Heikura, S. Jauhiainen, H.-K. Jyrkkanen, E. Kansanen, K. Maatta, E. Romppanen, P. Turunen, J. Rutanen, et al.
Nrf2 Gene Transfer Induces Antioxidant Enzymes and Suppresses Smooth Muscle Cell Growth In Vitro and Reduces Oxidative Stress in Rabbit Aorta In Vivo
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 741 - 747.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. K. Mehta and K. K. Griendling
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C82 - C97.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.